Cargando…

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?

Detalles Bibliográficos
Autores principales:	Rangaka, Molebogeng X, Hamada, Yohhei, Abubakar, Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942476/ https://www.ncbi.nlm.nih.gov/pubmed/35338839 http://dx.doi.org/10.1016/S2213-2600(22)00123-0

Ejemplares similares

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
por: Hamada, Yohhei, et al.
Publicado: (2021)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

A Systematic Review on the Safety of Mycobacterium tuberculosis–Specific Antigen–Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests
por: Hamada, Yohhei, et al.
Publicado: (2023)

Tracking COVID-19 using online search
por: Lampos, Vasileios, et al.
Publicado: (2021)

The impact of COVID-19 on global tuberculosis control
por: Lipman, Marc, et al.
Publicado: (2021)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape
por: Hamada, Yohhei, et al.
Publicado: (2022)

Is France Once Again Looking for a Scapegoat?
por: Lederman, Michael M., et al.
Publicado: (2021)

The syndemic of “COVID-19 and tuberculosis”
por: Das, Nikunja K., et al.
Publicado: (2022)

Challenges and opportunities to end tuberculosis in the COVID-19 era
por: Wingfield, Tom, et al.
Publicado: (2021)

World Tuberculosis Day 2022: aligning COVID-19 and tuberculosis innovations to save lives and to end tuberculosis
por: Ntoumi, Francine, et al.
Publicado: (2022)

India’s syndemic of tuberculosis and COVID-19
por: Shrinivasan, Rukmini, et al.
Publicado: (2020)

Reply to the syndemic of “COVID-19 and tuberculosis”
por: Patil, Rajashri A., et al.
Publicado: (2023)

Institutionalized Violence and Demystification of the Scapegoat in Guerra en El Paraíso
por: Franco Castillo, Carlos Humberto, et al.
Publicado: (2022)

“Scapegoat” for Offline Consumption: Online Review Response to Social Exclusion
por: Liang, Shichang, et al.
Publicado: (2021)

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
por: Gupta, Rishi K, et al.
Publicado: (2020)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

“We are Scapegoats”: Front-Line Nursing Home Staff Experiences During the COVID-19 Pandemic
por: White, Elizabeth, et al.
Publicado: (2020)

Thrombotic Thrombocytopenic Purpura After Live Liver Donation: Villain or Scapegoat?
por: Udayasankar, Madhumita, et al.
Publicado: (2021)

Ending tuberculosis by 2030: understanding the transmission
por: Pandey, Basu Dev, et al.
Publicado: (2023)

Diabetes and tuberculosis: A syndemic complicated by COVID-19()()
por: Antonio-Arques, Violeta, et al.
Publicado: (2021)

The cost of convenience: potential linkages between noncommunicable diseases and meal delivery apps
por: Halloran, Afton, et al.
Publicado: (2021)

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment
por: Riou, Catherine, et al.
Publicado: (2020)

COVID-19 'syndemic'
por: Takao, C., et al.
Publicado: (2021)

The syndemic challenge of tuberculosis and tobacco use
por: Siddiqi, Kamran, et al.
Publicado: (2021)

COVID-19 will continue but the end of the pandemic is near
por: Murray, Christopher J L
Publicado: (2022)

Monitoring inequalities is a key part of the efforts to end AIDS, tuberculosis, and malaria
por: Hosseinpoor, Ahmad Reza, et al.
Publicado: (2022)

Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
por: Rangaka, Molebogeng X, et al.
Publicado: (2021)

Evaluating the effect of short-course rifapentine-based regimens with or without enhanced behaviour-targeted treatment support on adherence and completion of treatment for latent tuberculosis infection among adults in the UK (RID-TB: Treat): protocol for an open-label, multicentre, randomised controlled trial
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1
por: Lesosky, Maia, et al.
Publicado: (2019)

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
por: Naidoo, Pren, et al.
Publicado: (2017)

COVID-19 as a Syndemic
por: Courtin, Emilie, et al.
Publicado: (2021)

Mass testing to end the COVID-19 public health threat
por: Philippe, Cecile, et al.
Publicado: (2023)

COVID-19 and global childhood tuberculosis notifications
por: Atre, Sachin, et al.
Publicado: (2022)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Tuberculosis — Reaping benefits from COVID-19 in Portugal
por: Mateiro Gomes, B.L., et al.
Publicado: (2021)

Learning from COVID-19 to reimagine tuberculosis diagnosis
por: Ruhwald, Morten, et al.
Publicado: (2021)

COVID-19 in systemic vasculitis and polymyalgia rheumatica: who is at risk of poor outcomes?
por: Monti, Sara
Publicado: (2021)

COVID-19: An opportunity to combat the burden of poor mental health in Australian workplaces
por: Taouk, Yamna, et al.
Publicado: (2022)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_qh35h92aghs4f93ig0u2mgvlmg